Literature DB >> 23090496

A review on the current neuroligin mouse models.

Jun-Yu Xu1, Qiang-Qiang Xia, Jun Xia.   

Abstract

Neuroligins (NLs) are postsynaptic membrane proteins expressed in the brain and mediate synaptogenesis. Neuroligin family proteins can specifically induce either excitatory or inhibitory synapses. Deletions or point mutations in neuroligin genes are found in patients with autism spectrum disorders (ASD) or mental retardations. The dysfunctions of these mutations have been tested in multiple neuroligin mouse models. In most of the models, including the human autism-linked NL3 and NL4 mutation mice, there are social interaction defects, memory impairment and repetitive behaviors. Researchers also found the excitatory/inhibitory synapse ratio altered in those mice, as well as receptor subunit composition. However, inconsistencies and debates also exist between different research approaches. In this review, we summarize the neuroligin mouse models currently available, examine the detailed alterations detected in those mice and compare the differences within different mouse models or different investigation methods, to obtain an overall picture of the current progress on neuroligin mouse models.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23090496

Source DB:  PubMed          Journal:  Sheng Li Xue Bao        ISSN: 0371-0874


  6 in total

1.  Conserved and divergent processing of neuroligin and neurexin genes: from the nematode C. elegans to human.

Authors:  Fernando Calahorro
Journal:  Invert Neurosci       Date:  2014-08-23

2.  Towards identification of individual etiologies by resolving genomic and biological conundrums in patients with autism spectrum disorders.

Authors:  M Poot
Journal:  Mol Syndromol       Date:  2013-04-04

Review 3.  Function, therapeutic potential and cell biology of BACE proteases: current status and future prospects.

Authors:  Robert Vassar; Peer-Hendrik Kuhn; Christian Haass; Matthew E Kennedy; Lawrence Rajendran; Philip C Wong; Stefan F Lichtenthaler
Journal:  J Neurochem       Date:  2014-04-19       Impact factor: 5.372

4.  Targeting Glia with N-Acetylcysteine Modulates Brain Glutamate and Behaviors Relevant to Neurodevelopmental Disorders in C57BL/6J Mice.

Authors:  Alice M S Durieux; Cathy Fernandes; Declan Murphy; Marie Anais Labouesse; Sandra Giovanoli; Urs Meyer; Qi Li; Po-Wah So; Grainne McAlonan
Journal:  Front Behav Neurosci       Date:  2015-12-14       Impact factor: 3.558

5.  Modeling non-syndromic autism and the impact of TRPC6 disruption in human neurons.

Authors:  K Griesi-Oliveira; A Acab; A R Gupta; D Y Sunaga; T Chailangkarn; X Nicol; Y Nunez; M F Walker; J D Murdoch; S J Sanders; T V Fernandez; W Ji; R P Lifton; E Vadasz; A Dietrich; D Pradhan; H Song; G-L Ming; X Gu; G Haddad; M C N Marchetto; N Spitzer; M R Passos-Bueno; M W State; A R Muotri
Journal:  Mol Psychiatry       Date:  2014-11-11       Impact factor: 15.992

6.  General developmental health in the VPA-rat model of autism.

Authors:  Mônica R Favre; Tania R Barkat; Deborah Lamendola; Georges Khazen; Henry Markram; Kamila Markram
Journal:  Front Behav Neurosci       Date:  2013-07-24       Impact factor: 3.558

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.